+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Oncology NGS"

Genomics Market By Product & Service, By Application, By End User, By Technology, By Regional Outlook, Industry Analysis Report and Forecast, 2021-2027 - Product Thumbnail Image

Genomics Market By Product & Service, By Application, By End User, By Technology, By Regional Outlook, Industry Analysis Report and Forecast, 2021-2027

  • Report
  • January 2022
  • 292 Pages
  • Global
From
Clinical Oncology Next Generation Sequencing Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Clinical Oncology Next Generation Sequencing Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • October 2023
  • 130 Pages
  • Global
From
Loading Indicator

The Oncology NGS market is a subset of the biotechnology industry that focuses on the development of technologies and products related to the diagnosis and treatment of cancer. This includes the use of next-generation sequencing (NGS) to identify genetic mutations in cancer cells, as well as the development of targeted therapies and immunotherapies to treat cancer. NGS is a powerful tool for cancer research, as it can provide a comprehensive view of the genetic makeup of a tumor, allowing for more accurate diagnosis and treatment. The Oncology NGS market is highly competitive, with a number of companies offering products and services related to cancer diagnosis and treatment. These include Illumina, Thermo Fisher Scientific, BGI, Agilent Technologies, and Qiagen. Additionally, there are a number of smaller companies that specialize in specific areas of oncology NGS, such as bioinformatics, data analysis, and drug development. Show Less Read more